Aralez Pharmaceuticals Stock Net Income
Aralez Pharmaceuticals fundamentals help investors to digest information that contributes to Aralez Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Aralez Stock. The fundamental analysis module provides a way to measure Aralez Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aralez Pharmaceuticals stock.
Aralez |
Aralez Pharmaceuticals Company Net Income Analysis
Aralez Pharmaceuticals' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Aralez Pharmaceuticals Net Income | (117.47 M) |
Most of Aralez Pharmaceuticals' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aralez Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Aralez Pharmaceuticals reported net income of (117.47 Million). This is 134.42% lower than that of the sector and 69.5% lower than that of the Net Income industry. The net income for all United States stocks is 120.57% higher than that of the company.
Aralez Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aralez Pharmaceuticals' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aralez Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Aralez Pharmaceuticals by comparing valuation metrics of similar companies.Aralez Pharmaceuticals is currently under evaluation in net income category among related companies.
Aralez Fundamentals
| Return On Equity | -262.08 | |||
| Return On Asset | -6.75 | |||
| Profit Margin | (99.50) % | |||
| Operating Margin | (45.33) % | |||
| Current Valuation | 233.57 M | |||
| Shares Outstanding | 67.19 M | |||
| Shares Owned By Insiders | 9.58 % | |||
| Shares Owned By Institutions | 8.27 % | |||
| Number Of Shares Shorted | 2.97 M | |||
| Price To Earning | (0.85) X | |||
| Price To Book | 2.21 X | |||
| Price To Sales | 0.15 X | |||
| Revenue | 118.06 M | |||
| Gross Profit | 92.44 M | |||
| EBITDA | (17.23 M) | |||
| Net Income | (117.47 M) | |||
| Cash And Equivalents | 43.89 M | |||
| Cash Per Share | 0.65 X | |||
| Total Debt | 274.57 M | |||
| Current Ratio | 0.80 X | |||
| Book Value Per Share | (0.10) X | |||
| Cash Flow From Operations | (20.7 M) | |||
| Short Ratio | 2.14 X | |||
| Earnings Per Share | (1.76) X | |||
| Number Of Employees | 164 | |||
| Beta | 0.88 | |||
| Market Capitalization | 17.93 M | |||
| Total Asset | 32.26 M | |||
| Retained Earnings | (134.69 M) | |||
| Working Capital | 15.52 M | |||
| Current Asset | 32.01 M | |||
| Current Liabilities | 16.49 M | |||
| Z Score | -2.6 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Aralez Stock
If you are still planning to invest in Aralez Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aralez Pharmaceuticals' history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |